QURA develops ultra-miniature implantable devices that continuously monitor physiological pressure changes in real-time. These devices provide critical data for early detection of health issues, enhancing patient care and enabling timely medical interventions.
Funding
$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ICFounders
Product
Problem
Continuous monitoring of physiological pressure changes is crucial for early detection and management of various health conditions. Traditional methods often involve invasive procedures or bulky, external devices, limiting patient comfort and accessibility for continuous, real-time data acquisition.
Solution
QURA is developing ultra-miniature, fully implantable sensors designed for continuous, real-time monitoring of physiological pressure. These wireless devices aim to provide clinicians with high-fidelity data, enabling proactive and personalized patient care. By offering a less invasive and more convenient monitoring solution, QURA seeks to improve the early detection of critical health issues and facilitate timely medical interventions. The sensors are designed for long-term use, minimizing the need for frequent replacements or adjustments.
Target Audience
The primary target audience includes physicians, hospitals, and medical researchers focused on proactive patient care and early disease detection through continuous physiological monitoring.
Features
- Fully implantable, ultra-miniature design for minimal invasiveness
- Continuous, real-time monitoring of physiological pressure changes
- Wireless data transmission for convenient data access
- Long-term durability and biocompatibility for extended use